Correction

Published on 20 Apr 2022

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

in Cancer Molecular Targets and Therapeutics

Yee Kit Tai
Karen Ka Wing Chan
Charlene Hui Hua Fong
Sharanya Ramanan
Jasmine Lye Yee Yap
Jocelyn Naixin Yin
Yun Sheng Yip
Wei Ren Tan
Angele Pei Fern Koh
Nguan Soon Tan

Frontiers in Oncology

doi 10.3389/fonc.2022.892408

1,515 views

Mini Review

Published on 14 Apr 2022

Osimertinib-Centered Therapy Against Uncommon Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer- A Mini Review

in Cancer Molecular Targets and Therapeutics

Chengyang Song
Xueying Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.834585

4,632 views
4 citations

Review

Published on 14 Apr 2022

Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer

in Cancer Molecular Targets and Therapeutics

Muchun Li
Xiaozhen Zhang
Xueli Bai
Tingbo Liang

Frontiers in Oncology

doi 10.3389/fonc.2022.862154

10,748 views
11 citations

Case Report

Published on 14 Apr 2022

Olaparib Combined With Dacomitinib in Osimertinib-Resistant Brain and Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Report and Systematic Review

in Cancer Molecular Targets and Therapeutics

Hui Zhang
Yong Wang
Huaguo Wu
Shizhen Zhou
Shuo Li
Xiangji Meng
Rongjie Tao
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.877279

4,738 views
9 citations

Editorial

Published on 14 Apr 2022

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers

in Cancer Molecular Targets and Therapeutics

Ziwen Lu
Hanqing Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.904032

1,078 views

Original Research

Published on 13 Apr 2022

Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression

in Cancer Molecular Targets and Therapeutics

Yubo Shi
Yunyun Tian
Xiangran Sun
Yonglong Qiu
Yingchun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.889583

1,550 views
8 citations

Original Research

Published on 12 Apr 2022

The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells

in Cancer Molecular Targets and Therapeutics

Xiangyu Ma
Mengjie Zhao
Zhuo-Xun Wu
Jingfang Yao
Lei Zhang
Jinhong Wang
Zhenbo Hu
Liuya Wei
Zhe-Sheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.855570

2,064 views
5 citations

Original Research

Published on 11 Apr 2022

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma

in Cancer Molecular Targets and Therapeutics

Linjun Liang
Hongfa Xu
Qichao Dong
Lige Qiu
Ligong Lu
Qing Yang
Wei Zhao
Yong Li

Frontiers in Oncology

doi 10.3389/fonc.2022.852000

2,596 views
5 citations

Original Research

Published on 11 Apr 2022

MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer

in Cancer Molecular Targets and Therapeutics

Tao Wang
Peng Zhang
Chengguo Li
Weizhen Liu
Qian Shen
Lei Yang
Gengchen Xie
Jie Bai
Ruidong Li
Kaixiong Tao

Frontiers in Oncology

doi 10.3389/fonc.2022.844135

3,430 views
8 citations

Review

Published on 08 Apr 2022

MRKNs: Gene, Functions, and Role in Disease and Infection

in Cancer Molecular Targets and Therapeutics

Tongtong Wang
Wenqiang Liu
Changfa Wang
Xuelian Ma
Muhammad Faheem Akhtar
Yubao Li
Liangliang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.862206

4,925 views
5 citations

Review

Published on 06 Apr 2022

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

in Cancer Molecular Targets and Therapeutics

Jeremy M. Kelm
Amirreza Samarbakhsh
Athira Pillai
Pamela S. VanderVere-Carozza
Hariprasad Aruri
Deepti S. Pandey
Katherine S. Pawelczak
John J. Turchi
Navnath S. Gavande

Frontiers in Oncology

doi 10.3389/fonc.2022.850883

7,776 views
16 citations

Perspective

Published on 05 Apr 2022

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy

in Cancer Molecular Targets and Therapeutics

Ji Wang
Chao Chen
Lu Wang
Mingjun Xie
Xinyang Ge
Sufan Wu
Yong He
Xiaozhou Mou
Chenyang Ye
Yi Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.872531

11,277 views
24 citations

Review

Published on 04 Apr 2022

TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy

in Cancer Molecular Targets and Therapeutics

Surui Liu
Jin Yu
Hui Zhang
Jie Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.860563

9,212 views
22 citations

Mini Review

Published on 04 Apr 2022

Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far

in Cancer Molecular Targets and Therapeutics

Shashanka K. Prasad
Smitha Bhat
Dharini Shashank
Akshatha C. R.
Sindhu R.
Pornchai Rachtanapun
Devananda Devegowda
Prasanna K. Santhekadur
Sarana Rose Sommano

Frontiers in Oncology

doi 10.3389/fonc.2022.836004

3,894 views
5 citations

Original Research

Published on 04 Apr 2022

Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer

in Cancer Molecular Targets and Therapeutics

Menghao Dong
Benjie Shan
Xinghua Han
Xiaotian Zhao
Fufeng Wang
Liuqing Zhu
Qiuxiang Ou
Xiaopeng Ma
Yueyin Pan

Frontiers in Oncology

doi 10.3389/fonc.2021.784985

4,063 views
8 citations

Original Research

Published on 31 Mar 2022

Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads

in Cancer Molecular Targets and Therapeutics

Adela Kiessling
Keerthana Ramanathan
Ola B. Nilsson
Luigi Notari
Stefanie Renken
Rolf Kiessling
Hans Grönlund
Stina L. Wickström

Frontiers in Oncology

doi 10.3389/fonc.2022.866763

5,193 views
3 citations

Navigation group

Articles

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

Osimertinib-Centered Therapy Against Uncommon Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer- A Mini Review

Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer

Olaparib Combined With Dacomitinib in Osimertinib-Resistant Brain and Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Report and Systematic Review

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers

Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression

The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma

MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer

MRKNs: Gene, Functions, and Role in Disease and Infection

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy

TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy

Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far

Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer

Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads